TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,648 | -65.5% | 61,800 | +2.5% | 0.02% | -64.7% |
| Q2 2023 | $1,497,852 | +52.5% | 60,300 | -7.7% | 0.07% | +44.7% |
| Q1 2023 | $982,112 | +20.7% | 65,300 | -5.1% | 0.05% | +4.4% |
| Q4 2022 | $813,904 | +317.4% | 68,800 | +109.1% | 0.04% | +275.0% |
| Q3 2022 | $195,000 | +9.6% | 32,900 | -21.7% | 0.01% | +9.1% |
| Q2 2022 | $178,000 | +9.2% | 42,000 | +145.6% | 0.01% | +37.5% |
| Q1 2022 | $163,000 | -63.6% | 17,100 | -27.5% | 0.01% | -66.7% |
| Q4 2021 | $448,000 | -23.9% | 23,600 | +33.3% | 0.02% | -29.4% |
| Q3 2021 | $589,000 | +390.8% | 17,700 | +608.0% | 0.03% | +580.0% |
| Q1 2021 | $120,000 | +15.4% | 2,500 | +25.0% | 0.01% | 0.0% |
| Q4 2020 | $104,000 | +300.0% | 2,000 | +100.0% | 0.01% | +150.0% |
| Q3 2020 | $26,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |